Search Browse Earnings

INTENSITY THERAPEUTICS, INC. — SlamSEC

INTENSITY THERAPEUTICS, INC.

Nasdaq:INTS

Biological Products, (No Diagnostic Substances)·SHELTON, CT

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

—

Adj. EBITDA

—

Net Income

-$10.5M

FY 2024

EPS (Diluted)

-$1.38

FY 2024

Stock Price

$7.91

+1.3%

2026-03-11

52W Range

$4.63 – $62.49

P/E Ratio

-5.7x

Market Cap

$475.1M

Cash

$8.6M

FY 2024

Total Debt

—

Net Cash

$8.6M

Enterprise Value

$466.6M

Debt / EBITDA

—

EV / EBITDA

—

Employees

—

CFO

Wesolowski John M